FDA-cleared profile

Velmeni for Dentists (V4D)

Velmeni Inc. · X-ray/Radiography · FDA-cleared (510(k))

Authorized purpose: VELMENI for DENTISTS is concurrent-read, computer-assisted detection software intended to assist dentists in the clinical detection of dental caries, fillings or restorations, fixed prostheses, and implants in digital bitewing, periapical, and panoramic radiographs of permanent teeth in patients 15 years of age or older. It provides additional information for dentists and is not a replacement for complete examination or clinical judgment; final diagnoses and treatment plans are the dentist's responsibility.

Clinical role
Radiographic image acquisition support, image processing, measurement, planning, or concurrent review under professional control.
Images and patients
X-ray/Radiography · Permanent teeth; digital bitewing, periapical, and panoramic dental radiographs
Key limitation
Keep in mind: The FDA table reports subgroup reader-study endpoints for the exact V4D submission; do not generalize them beyond the labeled dental radiograph types, permanent-tooth population, conditions, study design, or tested version.

Overview status: Source-reviewed overview

Report a correction
Clinical details Purpose, workflow fit, evidence, and safety record

Workflow navigation pilot

Workflow role has not yet been reviewed for this navigation pilot.

A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources

  • What does this software do?Authorized purpose: VELMENI for DENTISTS is concurrent-read, computer-assisted detection software intended to assist dentists in the clinical detection of dental caries, fillings or restorations, fixed prostheses, and implants in digital bitewing, periapical, and panoramic radiographs of permanent teeth in patients 15 years of age or older. It provides additional information for dentists and is not a replacement for complete examination or clinical judgment; final diagnoses and treatment plans are the dentist's responsibility.
  • Which images or clinical context are in scope?Modality: X-ray/Radiography Anatomy or clinical context: Permanent teeth; digital bitewing, periapical, and panoramic dental radiographs Input: Supported X-ray, radiographic, EOS, dental, or other labeled image inputs and associated study data.
  • Who uses it?Intended users: Radiologists, dentists, orthopedic clinicians, and other trained radiographic professionals within the labeled use.
  • What does the software produce?Output: Processed radiographs, measurements, landmarks, annotations, planning views, and review information for professional use.
  • What is its most important limitation?Key limitation: The FDA table reports subgroup reader-study endpoints for the exact V4D submission; do not generalize them beyond the labeled dental radiograph types, permanent-tooth population, conditions, study design, or tested version.

Clinical takeaway. Clinical role: VELMENI for DENTISTS is concurrent-read, computer-assisted detection software intended to assist dentists in the clinical detection of dental caries, fillings or restorations, fixed prostheses, and implants in digital bitewing, periapical, and panoramic radiographs of permanent teeth in patients 15 years of age or older. It provides additional information for dentists and is not a replacement for complete examination or clinical judgment; final diagnoses and treatment plans are the dentist's responsibility.

Evidence takeaway. Evidence from the reviewed source record: The exact FDA document reports software verification and validation, a standalone study on 600 Bitewing, 597 Periapical and 600 Panoramic images against consensus labels of three US licensed dentists, and a multi-reader fully crossed reader improvement study with 12 US licensed dentists. Standalone caries lesion-level sensitivity was 72.8% (68.0%, 77.4%) bitewing, 70.6% (64.1%, 76.6%) periapical and 68.3% (64.9%, 71.8%) panoramic. Bitewing lesion-level caries wAFROC AUC was 0.848 aided versus 0.794 unaided, difference 0.054 (0.035, 0.073). Results are as reported in the FDA submission, not independent validation.

Evidence context

Evidence context not reviewed for this FDA record.

Public-label constraints

Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.

Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.

Purpose
VELMENI for DENTISTS is concurrent-read, computer-assisted detection software intended to assist dentists in the clinical detection of dental caries, fillings or restorations, fixed prostheses, and implants in digital bitewing, periapical, and panoramic radiographs of permanent teeth in patients 15 years of age or older. It provides additional information for dentists and is not a replacement for complete examination or clinical judgment; final diagnoses and treatment plans are the dentist's responsibility.
  • Exact FDA submission
  • Checked 2026-09-04
Workflow role
Radiographic image acquisition support, image processing, measurement, planning, or concurrent review under professional control.
  • Exact FDA submission
  • Checked 2026-09-04
Required input
Supported X-ray, radiographic, EOS, dental, or other labeled image inputs and associated study data.
  • Exact FDA submission
  • Checked 2026-09-04
Output and clinician action
Processed radiographs, measurements, landmarks, annotations, planning views, and review information for professional use.
  • Exact FDA submission
  • Checked 2026-09-04
Care setting
Radiographic, orthopedic, dental, or clinical image-review settings within the labeled scope.
  • Exact FDA submission
  • Checked 2026-09-04
Intended users
Radiologists, dentists, orthopedic clinicians, and other trained radiographic professionals within the labeled use.
  • Exact FDA submission
  • Checked 2026-09-04
Limitations
The FDA table reports subgroup reader-study endpoints for the exact V4D submission; do not generalize them beyond the labeled dental radiograph types, permanent-tooth population, conditions, study design, or tested version.
  • Exact FDA submission
  • Checked 2026-09-04
Evidence summary
The exact FDA document reports software verification and validation, a standalone study on 600 Bitewing, 597 Periapical and 600 Panoramic images against consensus labels of three US licensed dentists, and a multi-reader fully crossed reader improvement study with 12 US licensed dentists. Standalone caries lesion-level sensitivity was 72.8% (68.0%, 77.4%) bitewing, 70.6% (64.1%, 76.6%) periapical and 68.3% (64.9%, 71.8%) panoramic. Bitewing lesion-level caries wAFROC AUC was 0.848 aided versus 0.794 unaided, difference 0.054 (0.035, 0.073). Results are as reported in the FDA submission, not independent validation.
  • Exact FDA submission
  • Checked 2026-11-14

Packet wording: "VELMENI FOR DENTISTS (V4D) passed all verification and validation software tests." … "Standalone performance of the Velmeni for Dentists (V4D) was evaluated on a total of 600 Bitewing images, 597 Periapical images and 600 Panoramic images.". Read from the exact FDA decision document on 2026-11-14.

Evidence

Performance evidence

Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.

Evidence summary
The exact FDA document reports software verification and validation, a standalone study on 600 Bitewing, 597 Periapical and 600 Panoramic images against consensus labels of three US licensed dentists, and a multi-reader fully crossed reader improvement study with 12 US licensed dentists. Standalone caries lesion-level sensitivity was 72.8% (68.0%, 77.4%) bitewing, 70.6% (64.1%, 76.6%) periapical and 68.3% (64.9%, 71.8%) panoramic. Bitewing lesion-level caries wAFROC AUC was 0.848 aided versus 0.794 unaided, difference 0.054 (0.035, 0.073). Results are as reported in the FDA submission, not independent validation.
  • FDA source
  • Exact FDA submission
  • Checked 2026-11-14

Packet wording: "VELMENI FOR DENTISTS (V4D) passed all verification and validation software tests." … "Standalone performance of the Velmeni for Dentists (V4D) was evaluated on a total of 600 Bitewing images, 597 Periapical images and 600 Panoramic images.". Read from the exact FDA decision document on 2026-11-14.

Reported sensitivity
Standalone lesion-level sensitivity for caries (600 Bitewing, 597 Periapical, 600 Panoramic images): bitewing 72.8% (95% CI 68.0%, 77.4%); periapical 70.6% (95% CI 64.1%, 76.6%); panoramic 68.3% (95% CI 64.9%, 71.8%).
  • FDA source
  • Exact FDA submission
  • Checked 2026-11-14

Packet wording: "Standalone performance of the Velmeni for Dentists (V4D) was evaluated on a total of 600 Bitewing images, 597 Periapical images and 600 Panoramic images." … "Table 2, Lesion-Level Sensitivity for Caries Caries View Lesion-Level Sensitivity( 95% CI1 ) Bitewing Views 72.8% (68.0%, 77.4%) Periapical Views 70.6% (64.1%, 76.6%) Panoramic Views 68.3% (64.9%, 71.8%)". Read from the exact FDA decision document on 2026-11-14; this is the submission-reported standalone result, not independent validation.

Reported specificity
Standalone case-level specificity for caries: bitewing 88.0% (95% CI 84.4%, 91.2%); periapical 84.7% (95% CI 81.4%, 87.9%); panoramic 96.8% (95% CI 94.6%, 98.6%).
  • FDA source
  • Exact FDA submission
  • Checked 2026-11-14

Packet wording: "Standalone study assessed sensitivity, specificity and dice coefficient." … "Table 3, Lesion-level and case-level sensitivity for caries, fixed prothesis, implants and restorations and dice coefficient for lesion segmentation. Results Assessment Bitewing Views Periapical Views Panoramic Views". Read from the exact FDA decision document on 2026-11-14; this is the submission-reported standalone result, not independent validation.

Fixed-prosthesis lesion-level sensitivity

88.8 percent

  • EndpointLesion-level sensitivity in the FDA comparison table
  • PopulationFDA reader-study subgroup for fixed prostheses on labeled dental radiographs
  • Tested versionVelmeni for Dentists (V4D) configuration described in K240003

Fixed-prosthesis case-level specificity

97.6 percent

  • EndpointCase-level specificity in the FDA comparison table
  • PopulationFDA reader-study subgroup for fixed prostheses on labeled dental radiographs
  • Tested versionVelmeni for Dentists (V4D) configuration described in K240003

Implant lesion-level sensitivity

88.3 percent

  • EndpointLesion-level sensitivity in the FDA comparison table
  • PopulationFDA reader-study subgroup for implants on labeled dental radiographs
  • Tested versionVelmeni for Dentists (V4D) configuration described in K240003

Restoration lesion-level sensitivity

73 percent

  • EndpointLesion-level sensitivity in the FDA comparison table
  • PopulationFDA reader-study subgroup for restorations on labeled dental radiographs
  • Tested versionVelmeni for Dentists (V4D) configuration described in K240003

Restoration case-level specificity

85.8 percent

  • EndpointCase-level specificity in the FDA comparison table
  • PopulationFDA reader-study subgroup for restorations on labeled dental radiographs
  • Tested versionVelmeni for Dentists (V4D) configuration described in K240003

K240003 FDA decision evidence package for Velmeni for Dentists (V4D)

  • DesignFDA decision evidence including the exact submission's labeled performance or verification material; endpoints remain submission-specific.
  • PopulationPermanent teeth; digital bitewing, periapical, and panoramic dental radiographs
  • Scopeexact submission
  • Tested versionVelmeni for Dentists (V4D) configuration described in K240003
  • IndependenceSponsor or vendor study

K240003

FDA decision material is manufacturer-submitted regulatory evidence. It is not independent clinical validation unless the exact source expressly establishes that distinction; local technical, clinical, privacy, security, and workflow acceptance remains necessary.

Safety and lifecycle

Postmarket record

Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.

Postmarket safety review
The 2026-09-02 openFDA device-recall snapshot contained no record matched to K240003 by exact native submission identifier. This does not exclude product-family, later-version, or adverse-event information.
  • Public source
  • Exact FDA submission
  • Checked 2026-09-04

Exact-identifier review does not prove absence of all product-family safety signals.

Pricing & contracts Public price, contract terms, and reimbursement

Price not public here; enter your quote

Not publicly available: Reviewed sources do not publish an exact-product procurement price with a stated offer scope.

Reimbursement

IT implementation Deployment, interfaces, data handling, and support

System and version relationships

Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.

No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.

Review Merge, Visage, Sectra, AGFA and IntelePACS context

Integration chain: evidence at each hop

Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.

Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner

No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.

  1. Acquisition/source

    Source context, not route validation: Supported X-ray, radiographic, EOS, dental, or other labeled image inputs and associated study data.

    Scope: Exact FDA submission.

    Confirm scanner/model, protocol, series completeness and both software builds.

    Field checked 2026-09-04 · FDA 510(k) decision material K240003: Velmeni for Dentists (V4D)

  2. Routing

    Source context, not route validation: The exact FDA package describes a non-medical VELMENI BRIDGE interface that acts as a conduit for data and information exchange between the V4D Backend API and third-party software such as patient management or imaging software. Interface versions and local compatibility require confirmation.

    Scope: Exact FDA submission. Packet wording: "The following non-medical interfaces are also available with VELMENI for DENTISTS (V4D):" … "VELMENI BRIDGE (VB) acts as a conduit enabling data and information exchange between Backend API and third-party software like Patient Management or Imaging Software". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.

    Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.

    Field checked 2026-11-14 · FDA 510(k) decision material K240003: Velmeni for Dentists (V4D)

  3. AI processing

    Source context, not route validation: The exact FDA package describes V4D as cloud-hosted software, with a web application interface as the point of interaction between the device and the user. Current hosting, data flow, and commercial configuration require vendor confirmation.

    Scope: Exact FDA submission. Packet wording: "Web Application Interface delivers front-end capabilities and is the point of interaction between the device and the user." … "Cloud Yes Yes Yes Yes Hosted Software". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.

    Confirm processing location, queue ownership, exclusions and exact AI build.

    Field checked 2026-11-14 · FDA 510(k) decision material K240003: Velmeni for Dentists (V4D)

  4. Returned objects

    Source context, not route validation: Processed radiographs, measurements, landmarks, annotations, planning views, and review information for professional use.

    Scope: Exact FDA submission.

    Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.

    Field checked 2026-09-04 · FDA 510(k) decision material K240003: Velmeni for Dentists (V4D)

  5. Viewer/worklist/report

    Unresolved route: Processed radiographs, measurements, landmarks, annotations, planning views, and review information for professional use.

    Scope: Exact FDA submission.

    Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.

    Field checked 2026-09-04 · FDA 510(k) decision material K240003: Velmeni for Dentists (V4D)

  6. Support owner

    Unresolved route: Not established for the exact route.

    Scope: Scope not established.

    Name the local, platform and AI supplier support owners and escalation path.

Planned local route tests

No tests below have been performed or accepted.

  1. Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
  2. Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
  3. Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
  4. Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
  5. Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
  6. Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
  7. Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.

Local implementation checklist

Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.

Open the printable evaluation checklist

Deployment
The exact FDA package describes V4D as cloud-hosted software, with a web application interface as the point of interaction between the device and the user. Current hosting, data flow, and commercial configuration require vendor confirmation.
  • Exact FDA submission
  • Checked 2026-11-14

Packet wording: "Web Application Interface delivers front-end capabilities and is the point of interaction between the device and the user." … "Cloud Yes Yes Yes Yes Hosted Software". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.

Integration
The exact FDA package describes a non-medical VELMENI BRIDGE interface that acts as a conduit for data and information exchange between the V4D Backend API and third-party software such as patient management or imaging software. Interface versions and local compatibility require confirmation.
  • Exact FDA submission
  • Checked 2026-11-14

Packet wording: "The following non-medical interfaces are also available with VELMENI for DENTISTS (V4D):" … "VELMENI BRIDGE (VB) acts as a conduit enabling data and information exchange between Backend API and third-party software like Patient Management or Imaging Software". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.

Training
Only radiologists, dentists, orthopedic clinicians, and other trained radiographic professionals within the labeled use should operate or interpret the product. Local onboarding should cover the exact release, supported population, limitations, failure examples, escalation, downtime, and competency documentation.
  • Exact FDA submission
  • Checked 2026-09-04
Monitoring
Monitor K240003 by exact hardware, software, model, and algorithm version; patient population; anatomy; protocol; operator; input quality; output edits or overrides; failed studies; repeat acquisition or rework; downstream impact; downtime; incidents; recalls; and updates. Track these product-specific limits: The FDA table reports subgroup reader-study endpoints for the exact V4D submission; do not generalize them beyond the labeled dental radiograph types, permanent-tooth population, conditions, study design, or tested version.
  • Exact FDA submission
  • Checked 2026-09-04

This is buyer-facing monitoring guidance derived from the exact cleared scope; it is not a claim that the FDA package provides a live monitoring service.

Release and scope verification

Map installed model, build, options, population, anatomy, inputs, outputs, and enabled functions to K240003 before acceptance.

exact submission · checked 2026-09-04

Later product-family features are not evidence that this cleared or authorized release includes them.

Deployment boundary

The exact public deployment topology remains incomplete; establish hosting responsibility, data flow, availability, upgrade, service, and downtime boundaries locally.

exact submission · checked 2026-09-04

FDA-described topology does not establish current hosting contracts, security controls, uptime, or local qualification.

Interoperability acceptance

The exact public integration contract remains incomplete; establish and test supported input, output, identity, routing, archive, and downtime behavior locally.

exact submission · checked 2026-09-04

Test representative identifiers, orientation, geometry, measurements, units, routing, failure handling, and round trips locally.

Clinical acceptance

Use a signed local test set for the supported population and workflow. Include common and difficult cases, exclusions, acquisition variation, failed or low-quality inputs, reviewer overrides, and downstream effects. The FDA table reports subgroup reader-study endpoints for the exact V4D submission; do not generalize them beyond the labeled dental radiograph types, permanent-tooth population, conditions, study design, or tested version.

exact submission · checked 2026-09-04

Define stop-use, escalation, rollback, and revalidation triggers before production use.

Economic evaluation

Model capital and recurring cost against net staff time after review, throughput, repeat imaging or rework, room time, consumables, infrastructure, training, service, downtime, upgrade, and replacement costs.

exact submission · checked 2026-09-04

No exact-product price or reimbursement determination was promoted.

Lifecycle monitoring

Monitor K240003 by exact hardware, software, model, and algorithm version; patient population; anatomy; protocol; operator; input quality; output edits or overrides; failed studies; repeat acquisition or rework; downstream impact; downtime; incidents; recalls; and updates. Track these product-specific limits: The FDA table reports subgroup reader-study endpoints for the exact V4D submission; do not generalize them beyond the labeled dental radiograph types, permanent-tooth population, conditions, study design, or tested version.

exact submission · checked 2026-09-04

Revalidate after material software, hardware, model, protocol, interface, or clinical-policy changes.

Sources & review details FDA identity, research record, source ledger, and history

Regulatory identity

FDA record and catalog context

The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.

FDA submission
K240003
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Modality
X-ray/Radiography
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-04
Anatomy
Permanent teeth; digital bitewing, periapical, and panoramic dental radiographs
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-04
Clearance type
510(k)
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Decision date
2024-08-30
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
FDA status
FDA-cleared
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31

Research record

What has been checked

This audit distinguishes completed source review from fields that have not yet been researched.

Exact FDA record reviewedStatus
2026-09-20Last searched
27Fields reviewed
10Source classes checked
0Screened PubMed leads
0Screened trial leads
0Unreviewed FDA recall leads

The refreshed discovery snapshot contains no PubMed or ClinicalTrials.gov candidates; no external evidence was promoted. The current discovery snapshot contains 0 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.

Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.

Source classes: fda ai list, fda decision summary, acr ai central product, fda decision material, fda device recall, literature index, trial registry, pubmed, clinical trials, openfda device recall

Field review details

Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.

  • Public pricing: Not publicly available - checked 2026-09-04 - Exact FDA submission

    No public list price for the exact cleared or authorized configuration was found. Obtain a written quote separating license or hardware basis, implementation, interfaces, infrastructure, training, service, upgrades, renewal, consumables, and exit costs.

  • Pricing model: Not yet reviewed
  • Setup and integration fees: Not yet reviewed
  • Recurring fees: Not yet reviewed
  • Minimum commitment: Not yet reviewed
  • Contract duration: Not yet reviewed
  • Renewal terms: Not yet reviewed
  • Cancellation terms: Not yet reviewed
  • Support and service terms: Not yet reviewed
  • Trial or pilot terms: Not yet reviewed
  • Reimbursement: Not publicly available - checked 2026-09-04 - Exact FDA submission

    No exact-product reimbursement determination was promoted in this timeboxed review. Verify payer, site-of-service, coding, coverage, and local payment assumptions independently.

  • Data hosting location: Not yet reviewed
  • Data retention: Not yet reviewed
  • Documented data use: Not yet reviewed
  • Hardware requirements: Not yet reviewed
  • Network requirements: Not yet reviewed
  • Identity and access: Not yet reviewed
  • Security: Not publicly available - checked 2026-09-04 - Exact FDA submission

    Public materials reviewed for this exact release do not establish the complete security posture. Request data-flow, identity, audit, encryption, retention, remote-access, vulnerability-management, backup, and incident-response evidence.

  • Installation timeline: Not yet reviewed

6 sources - 3 history items

Source ledger

  1. FDA 510(k) decision material K240003: Velmeni for Dentists (V4D)

    U.S. Food and Drug Administration - Published 2024-08-30 - Accessed 2026-09-04

    Scope: identity, purpose, clinicalUse, modality, anatomy, intendedUsers, careSetting, workflowRole, input, output, limitations, evidenceSummary

  2. Artificial Intelligence-Enabled Medical Devices

    U.S. Food and Drug Administration - Accessed 2026-08-31

    Scope: regulatoryIdentity, modalityContext

  3. Velmeni for Dentists (V4D) model card (K240003)

    American College of Radiology - Published 2026-06-26 - Accessed 2026-09-01

  4. PubMed biomedical literature index

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery

  5. ClinicalTrials.gov study registry

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery, studyStatus

  6. openFDA Device Recall API

    U.S. Food and Drug Administration - Accessed 2026-09-02

    Scope: recallDiscovery, nativeSubmissionMatching

Research history

  1. K240003 FDA decision

    Regulatory record

    510(k)

  2. Source-review record updated

    Research record

    fda record reviewed

  3. Reader overview source-reviewed

    Editorial review

    Source-reviewed editorial overlay

Alternatives

Related tools to compare

FDA-cleared K252953

Velmeni for Dentists (V4D) Endo-Perio

Velmeni, Inc.

Authorized purpose: Concurrent-read CADe to assist dentists in detecting specified tooth and jaw anatomy, bone-level landmarks, and root-canal-treated teeth in digital radiographs of permanent teeth in patients 15 years or older.

Modality
X-ray/Radiography
Anatomy
Permanent teeth and jaw/maxillofacial anatomy, including enamel, dentine, pulp, root, mental foramen, inferior alveolar canal, maxillary sinus, cementoenamel junction, crestal bone, and root-canal-treated teeth
Decision
2026-05-11
FDA-cleared K253502

Critical Care Suite with Enteric Tube Positioning AI Algorithm

Ge Medical Systems, LLC

Authorized purpose: Analyze frontal chest and abdominal X-ray images to detect and localize a nasally or orally inserted enteric tube, its tip and side port if present, and the diaphragm and airways for radiologist review.

Modality
X-ray/Radiography
Anatomy
Chest/lung and abdomen/stomach; enteric tube, tube tip and side port, diaphragm, and airways including carina and left/right bronchi
Decision
2026-04-14
FDA-cleared K251934

qXR-Detect

Qure.Ai Technologies

Authorized purpose: qXR-Detect is an adult chest-radiograph concurrent reading aid that identifies, highlights and categorizes suspicious regions of interest across lung, pleura, mediastinum/hila/heart, bone, hardware and other categories; trained clinicians remain responsible for primary interpretation.

Modality
X-ray/Radiography
Anatomy
Chest/Lung; pleura, mediastinum/hila/heart, bone, hardware and other chest-radiograph regions
Decision
2026-01-16
FDA-cleared K250264

SugarBug (1.x)

Bench7, Inc.

Authorized purpose: Provides automated concurrent-read detection and segmentation of caries on bitewing radiographs in patients 18 and older, adding information for the dentist while requiring complete dentist review and judgment.

Modality
X-ray/Radiography
Anatomy
Dental/Maxillofacial
Decision
2025-11-07

Correct this exact record

Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.

Open existing correction destination

Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.

Accepted repository change history

No entry has been added to this scoped change history for this record. This is not proof that the record never changed.

Correction policy and limits · Public repository change history